Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Cyclophosphamide
100%
Teratogen
84%
Immunopotentiating Activity
53%
Apoptosis
46%
Tumor Necrosis Factor-α
43%
NF-B
35%
DNA Binding
32%
Branched DNA
30%
Blastocyst
29%
Fetoplacental Unit
27%
Teratogenic
27%
Fetus
26%
Pregnancy Loss
25%
Embryonic Cells
24%
Placenta
23%
Embryonic Development
22%
Rat Blastocysts
22%
Teratogenesis
22%
Diabetes
20%
Uterus
18%
Insults
18%
Liver
18%
Imuran
16%
Protector
16%
Mouse Embryo
16%
Cell Proliferation
15%
Mouse Embryonic Fibroblasts
15%
Nuclear factor-B
14%
Methotrexate
14%
QT Interval
14%
Preimplantation
14%
Activation Factor
14%
Embryotoxicity
14%
Mouse Preimplantation Embryo
14%
Lymphoid Organs
14%
Splenocytes
14%
ICR Mice
13%
Teratogenic Effects
12%
Resorption Rate
11%
High Dose
11%
Structural Anomalies
11%
Maldevelopment
11%
Malformation
11%
Female Mice
11%
Cell Population
10%
B-cell Lymphoma 2 (Bcl-2)
10%
Kidney
10%
MRNA Expression
10%
Knock-in Mouse Model
10%
Apoptotic Cells
10%
Pharmacology, Toxicology and Pharmaceutical Science
Cyclophosphamide
94%
Teratogenic Agent
65%
Protein P53
43%
Rat
42%
Tumor Necrosis Factor
37%
DNA B
33%
Teratogenesis
27%
Nuclear Factor
21%
Alternative Complement Pathway C3 C5 Convertase
21%
Azathioprine
21%
Caspase 3
15%
Caspase 8
11%
Institute for Cancer Research Mouse
10%
Knockout Mouse
8%
Caspase
8%
Teratogenicity
7%
Congenital Malformation
7%
Embryotoxicity
7%
Tumor Necrosis
7%
Sirenomelia
7%
Methotrexate
7%
Ciclosporin
7%
Retinoid
7%
Levan
7%
microRNA 125b
7%
Retinoic Acid
7%
Immunoglobulin Enhancer Binding Protein
7%
Rat Model
7%
Pneumoperitoneum
7%
microRNA
7%
microRNA 155
7%
Arginine
7%
Carbon Dioxide
7%
Glucose
7%
Doxorubicin
7%
Enzymes
7%
Transcription Factors
5%
Growth Retardation
5%
Embryo Death
5%